5347 articles
Waqaas Al-Siddiq, founder and CEO of Biotricity, Inc., a med tech company, discusses the role of AI in the future of wearable heart monitoring devices...
Dawn Johnson, a psychiatric nurse practitioner at the Indiana Center For Recovery discusses a survey that found that 94% of people agree that substance
Craig Coleman, PharmD, FASHP, FACC, Professor at the University of Connecticut discusses new data supporting XARELTO ® (rivaroxaban) efficacy and safet...
Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics, a biotech company, discusses the company's focus on bringing novel immuno-oncology thera...
Rakesh Amin, MD, discusses the toll that schizophrenia takes on caregivers, how caregivers of schizophrenia patients can best support themselves, as wel...
Hema Tallman, SVP and Global Head of BioLife Plasma Services at Takeda, an industry leader in the collection of high-quality plasma and a supporting dri...
David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patien...
Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person's relationships, physical health, and plans for the futur...
Mark McDonough, CEO of ChromaCode, a molecular diagnostics company, discusses how ChromaCode technology provides a cost-effective, rapid, and accurate...
Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare - the only pharmaceutical company solely focused on HIV, discusses...